NCT03429296

Autohypnosis and Cancerology

Prospective, Randomized Study Aiming to Assess the Benefit of Autohypnosis Learning in the Care of Patients Treated by Adjuvant Chemotherapy for Colorectal or Breast Cancer.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 120 (actual)
• Sponsor: Groupe Hospitalier Mutualiste de Grenoble · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Therapeutical hypnosis is proven to be an effective medical support to chemotherapy: it was shown that it can reduce the pain, anxiety, fatigue felt by the patient. Yet, hypnosis requires the presence of an hypnotherapist, which is why auto-hypnosis could be an efficient alternative to handle the side effects of chemotherapy. In this study, colorectal cancer and breast cancer patients are either taught auto-hypnosis or are taken in standard care for their chemotherapy. The life quality score (QLQC30) assessed during and after chemotherapies will determine if auto-hypnosis is a good medical support in chemotherapies' adverse effects management. The proven benefices of auto-hypnosis in the handling of the side effects of chemotherapies could improve the quality of life of cancer affected patients.

Conditions

• Colorectal Cancer
• Breast Cancer

Interventions

Type	Name	Description
OTHER	Autohypnosis learning	Patients are taught how to do auto-hypnosis by an hypnotherapist before all along their chemotherapy.

Timeline

• Start date: 2018-05-23
• Primary completion: 2022-01-21
• Completion: 2022-07-01
• First posted: 2018-02-12
• Last updated: 2023-03-07

Locations

1 site across 1 country: France